No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 79
Sex
Any
Study type
Observational
Participants needed
98 (estimated)
Sponsor
Tulane University School of Medicine · Other
Who this trial is looking for
This trial is looking for adults aged 18 to 79 with atrial fibrillation or those aged 40 to 79 at risk for heart disease. Participants will use wearable devices and undergo heart imaging over a year to monitor heart health.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 to 79 years old and have atrial fibrillation.
I am 40 to 79 years old and at moderate or high risk for heart disease.
I have internet and email access at home.
I have a compatible Android or iOS mobile device.
I can return for a clinic visit one year after my first appointment.
I can read, understand, and sign the consent form.
You may not be able to join if
I have health issues that prevent me from undergoing an MRI.
I weigh more than 300 lbs.
I have kidney problems.
I am pregnant now or become pregnant during the study.
I do not have internet or email access.
I do not have a compatible Android or iOS mobile device.
I have cognitive issues that affect my ability to use wearable devices.
I cannot return for a follow-up appointment a year after.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
Participants must meet the following criteria to be enrolled in the trial:
* Participants with atrial fibrillation aged 18 to 79 years old, or
* Participants aged 40 to 79 years old, at moderate or high risk for CVD as defined by the 10-year risk Atherosclerotic Cardiovascular …
Inclusion Criteria:
Participants must meet the following criteria to be enrolled in the trial:
* Participants with atrial fibrillation aged 18 to 79 years old, or
* Participants aged 40 to 79 years old, at moderate or high risk for CVD as defined by the 10-year risk Atherosclerotic Cardiovascular Disease (ASCVD), a validated risk calculation tool.
* Participants who have access to internet/e-mail in their homes.
* Participants who have access to a compatible Android mobile device or compatible iOS mobile device (iPhone 4S or newer, iPad 3 or newer).
* Participants who are able and willing to return to the study clinic one-year following their baseline CMR for a follow-up appointment and 12-month CMR.
* Participants who are able to read, understand, and sign the consent form.
Exclusion Criteria:
Participants will be excluded from enrollment if any of the following criteria are present:
* Any health-related gadolinium/MRI contraindications (e.g. allergy to gadolinium, pacemakers, Implantable Cardioverter Defibrillators (ICD's), other devices/implants contraindicated for use of MRI, etc.).
* Participants weighing \>300 lbs. (MRI quality decreases as BMI increases).
* Participants with renal insufficiency (Glomerular Filtration Rate (GFR) \<30 mL per minute per 1.73 m2) or acute/severe renal dysfunction/disease.
* Women who are pregnant at the time of enrollment/consent. (Should a participant become pregnant during the course of the study, no CMR will be performed until 10 days, postpartum).
* Participants who do not have access to the internet/e-mail.
* Participants who do not have a compatible Android mobile device or compatible iOS mobile device (iPhone 4S or newer, iPad 3 or newer).
* Participants with cognitive impairments affecting their ability to be compliant with wearing and maintaining wearable devices.
* Participants who are unable or unwilling to return to the study clinic one-year post baseline for their follow-up appointment and CMR.
* Participants with cognitive impairments who are unable to give informed consent.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
